Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2013-014
Jilin Zixin Pharmaceutical Co., Ltd. 2012 Annual Report Summary
1, important tips
The summary of this annual report comes from the full text of the annual report. Investors should read the full text of the annual report published on the website of the Shenzhen Stock Exchange and other websites of the China Securities Regulatory Commission.
Company Profile
|
Stock short name |
Zixin Pharmaceutical |
Stock code |
002118 |
|
|
Stock exchange |
Shenzhen Stock Exchange |
|||
|
Contact and contact information |
Secretary of the board |
Securities Affairs Representative |
||
|
Name |
Zhong Yunxiang |
Liang Shichang |
||
|
phone |
0431-81916633 |
0431-81916633 |
||
|
fax |
0431-88698366 |
0431-88698366 |
||
|
|
zixin@zxpc.cc |
zixin@zxpc.cc |
||
2. Major financial data and shareholder changes
(1) Main financial data
|
|
2012 |
year 2011 |
Increase or decrease this year (%) |
year 2010 |
|
Operating income (yuan) |
418,500,365.23 |
927,619,550.21 |
-54.88% |
642,417,445.93 |
|
Net profit attributable to shareholders of listed companies (yuan) |
86,311,393.11 |
217,289,950.92 |
-60.28% |
173,173,606.20 |
|
Net profit attributable to shareholders of a listed company after deducting non-recurring gains and losses (yuan) |
63,131,890.98 |
183,841,010.77 |
-65.66% |
176,477,838.56 |
|
Net cash flow from operating activities (yuan) |
-195,448,044.65 |
-558,721,219.61 |
-65.02% |
-215,418,190.86 |
|
Basic earnings per share (yuan/share) |
0.17 |
0.42 |
-59.52% |
0.37 |
|
Diluted earnings per share (yuan/share) |
0.17 |
0.42 |
-59.52% |
0.37 |
|
Weighted average return on equity (%) |
1.87% |
12.78% |
-10.91% |
33.36% |
|
|
End of 2012 |
End of 2011 |
Increase or decrease at the end of the year compared to the end of the previous year (%) |
End of 2010 |
|
Total assets (yuan) |
3,045,392,209.56 |
2,789,164,038.40 |
9.19% |
2,569,265,077.05 |
|
|